Search

everythinglearnresearchcommunity

for

Search:↓

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Androgens affect hair growth and shedding, with genetic and non-genetic factors influencing baldness.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Treatments for hair loss vary, but cell-based options may be the future.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Male pattern baldness involves genetics, hormones, and needs better treatments.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Certain sex hormones and antiandrogens can either slow down or speed up the growth of human hair follicle cells depending on their concentration.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.